WELL Health Technologies (TSE:WELL – Get Rating) had its target price decreased by equities research analysts at Canaccord Genuity Group from C$10.00 to C$6.00 in a research report issued on Friday, BayStreet.CA reports. Canaccord Genuity Group’s target price would suggest a potential upside of 63.04% from the stock’s previous close.
A number of other analysts also recently issued reports on WELL. CIBC cut their price objective on WELL Health Technologies from C$11.00 to C$8.00 and set an “outperform” rating for the company in a research report on Tuesday, January 25th. Pi Financial cut their price objective on WELL Health Technologies from C$10.50 to C$9.00 and set a “buy” rating for the company in a research report on Monday, April 4th. Haywood Securities reissued a “buy” rating and set a C$12.00 price objective on shares of WELL Health Technologies in a research report on Monday, April 25th. TD Securities cut their price objective on WELL Health Technologies from C$9.00 to C$7.00 and set a “buy” rating for the company in a research report on Friday. Finally, Eight Capital cut their price objective on WELL Health Technologies from C$13.00 to C$12.00 and set a “buy” rating for the company in a research report on Tuesday, April 5th. One investment analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, WELL Health Technologies currently has an average rating of “Buy” and a consensus price target of C$9.44.
Shares of TSE:WELL traded down C$0.13 during midday trading on Friday, reaching C$3.68. 754,563 shares of the company’s stock were exchanged, compared to its average volume of 1,076,113. The firm’s 50 day simple moving average is C$4.57 and its two-hundred day simple moving average is C$4.87. The company has a debt-to-equity ratio of 56.77, a current ratio of 1.04 and a quick ratio of 0.97. The stock has a market cap of C$782.96 million and a price-to-earnings ratio of -16.07. WELL Health Technologies has a fifty-two week low of C$3.65 and a fifty-two week high of C$8.86.
WELL Health Technologies Corp. operates as a practitioner focused digital health company in Canada, the United States, and internationally. It offers end-to-end omni-channel patient services, including primary care; physiotherapy, occupational therapy, chiropractic, dietary, mental health counselling, and sleep related services; specialized care, including gastroenterologists; diagnostic services related to cardiology, women's health, and bone/muscle health and cancer diagnostics; and telehealth services.
- 3 Retailers That Defied First Quarter Headwinds
- Rapid7: Could Be Profitable in FY 2022 Despite Bear Market
- Will John Deere’s Earnings Help to Calm the Markets?
- Lowe’s Companies Has Not Bottomed
- Silicon Labs Stock is Falling to a Better Place
Receive News & Ratings for WELL Health Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WELL Health Technologies and related companies with MarketBeat.com's FREE daily email newsletter.